Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 23-valent Vaccine
1.2.3 10-valent Vaccine
1.2.4 7-valent Vaccine
1.2.5 13-valent Vaccine
1.3 Market by Application
1.3.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Perspective (2018-2034)
2.2 Pneumococcal Conjugate Vaccine (PCV) Growth Trends by Region
2.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Region (2018-2023)
2.2.3 Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Region (2024-2034)
2.3 Pneumococcal Conjugate Vaccine (PCV) Market Dynamics
2.3.1 Pneumococcal Conjugate Vaccine (PCV) Industry Trends
2.3.2 Pneumococcal Conjugate Vaccine (PCV) Market Drivers
2.3.3 Pneumococcal Conjugate Vaccine (PCV) Market Challenges
2.3.4 Pneumococcal Conjugate Vaccine (PCV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue
3.1.1 Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Revenue (2018-2023)
3.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Players (2018-2023)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pneumococcal Conjugate Vaccine (PCV) Revenue
3.4 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio
3.4.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2024
3.5 Pneumococcal Conjugate Vaccine (PCV) Key Players Head office and Area Served
3.6 Key Players Pneumococcal Conjugate Vaccine (PCV) Product Solution and Service
3.7 Date of Enter into Pneumococcal Conjugate Vaccine (PCV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Type
4.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Type (2018-2023)
4.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2024-2034)
5 Pneumococcal Conjugate Vaccine (PCV) Breakdown Data by Application
5.1 Global Pneumococcal Conjugate Vaccine (PCV) Historic Market Size by Application (2018-2023)
5.2 Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pneumococcal Conjugate Vaccine (PCV) Market Size (2018-2034)
6.2 North America Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023)
6.4 North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size (2018-2034)
7.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023)
7.4 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size (2018-2034)
8.2 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023)
8.4 Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size (2018-2034)
9.2 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023)
9.4 Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size (2018-2034)
10.2 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023)
10.4 Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Introduction
11.1.4 Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Introduction
11.2.4 GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Introduction
11.3.4 Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Introduction
11.4.4 Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Walvax Biotechnology
11.5.1 Walvax Biotechnology Company Detail
11.5.2 Walvax Biotechnology Business Overview
11.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Introduction
11.5.4 Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.5.5 Walvax Biotechnology Recent Development
11.6 Royal (Wuxi) Bio-Pharmaceutical
11.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Detail
11.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
11.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Introduction
11.6.4 Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
11.7 Zhifei Biologic
11.7.1 Zhifei Biologic Company Detail
11.7.2 Zhifei Biologic Business Overview
11.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Introduction
11.7.4 Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.7.5 Zhifei Biologic Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Detail
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Introduction
11.8.4 Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
11.8.5 Serum Institute of India Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of 23-valent Vaccine
Table 3. Key Players of 10-valent Vaccine
Table 4. Key Players of 7-valent Vaccine
Table 5. Key Players of 13-valent Vaccine
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2018-2023)
Table 10. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2024-2034)
Table 12. Pneumococcal Conjugate Vaccine (PCV) Market Trends
Table 13. Pneumococcal Conjugate Vaccine (PCV) Market Drivers
Table 14. Pneumococcal Conjugate Vaccine (PCV) Market Challenges
Table 15. Pneumococcal Conjugate Vaccine (PCV) Market Restraints
Table 16. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players (2018-2023)
Table 18. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2024)
Table 19. Ranking of Global Top Pneumococcal Conjugate Vaccine (PCV) Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pneumococcal Conjugate Vaccine (PCV) Product Solution and Service
Table 23. Date of Enter into Pneumococcal Conjugate Vaccine (PCV) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2018-2023)
Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Type (2024-2034)
Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2018-2023)
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Application (2024-2034)
Table 33. North America Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (2024-2034) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product
Table 51. Pfizer Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. GSK Company Detail
Table 54. GSK Business Overview
Table 55. GSK Pneumococcal Conjugate Vaccine (PCV) Product
Table 56. GSK Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Sanofi Company Detail
Table 59. Sanofi Business Overview
Table 60. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product
Table 61. Sanofi Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 62. Sanofi Recent Development
Table 63. Merck Company Detail
Table 64. Merck Business Overview
Table 65. Merck Pneumococcal Conjugate Vaccine (PCV) Product
Table 66. Merck Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Walvax Biotechnology Company Detail
Table 69. Walvax Biotechnology Business Overview
Table 70. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product
Table 71. Walvax Biotechnology Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 72. Walvax Biotechnology Recent Development
Table 73. Royal (Wuxi) Bio-Pharmaceutical Company Detail
Table 74. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 75. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product
Table 76. Royal (Wuxi) Bio-Pharmaceutical Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 77. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 78. Zhifei Biologic Company Detail
Table 79. Zhifei Biologic Business Overview
Table 80. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product
Table 81. Zhifei Biologic Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 82. Zhifei Biologic Recent Development
Table 83. Serum Institute of India Company Detail
Table 84. Serum Institute of India Business Overview
Table 85. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product
Table 86. Serum Institute of India Revenue in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023) & (US$ Million)
Table 87. Serum Institute of India Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type: 2024 VS 2034
Figure 3. 23-valent Vaccine Features
Figure 4. 10-valent Vaccine Features
Figure 5. 7-valent Vaccine Features
Figure 6. 13-valent Vaccine Features
Figure 7. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application: 2024 VS 2034
Figure 9. Child Case Studies
Figure 10. Adult Case Studies
Figure 11. Pneumococcal Conjugate Vaccine (PCV) Report Years Considered
Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Pneumococcal Conjugate Vaccine (PCV) Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Region: 2024 VS 2034
Figure 15. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Players in 2024
Figure 16. Global Top Pneumococcal Conjugate Vaccine (PCV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2024
Figure 18. North America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2018-2034)
Figure 20. United States Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2018-2034)
Figure 24. Germany Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Pneumococcal Conjugate Vaccine (PCV) Market Share by Region (2018-2034)
Figure 32. China Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2018-2034)
Figure 40. Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Market Share by Country (2018-2034)
Figure 44. Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 47. GSK Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 49. Merck Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 50. Walvax Biotechnology Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 51. Royal (Wuxi) Bio-Pharmaceutical Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 52. Zhifei Biologic Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 53. Serum Institute of India Revenue Growth Rate in Pneumococcal Conjugate Vaccine (PCV) Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed